SciSparc Ltd. | TalkMarkets | Page 1
No data available
No data available

People who follow this stock (5)

View All

Latest Posts

About This Stock More About This Stock
SciSparc Might Become The Next GW Pharmaceuticals
Article By: Lorimer Wilson
Wednesday, March 24, 2021 9:38 AM EDT
With the Jazz Pharmaceuticals buyout of GW Pharmaceuticals, biotech marijuana stocks are in the spotlight and one of particular interest is SciSparc Ltd.
In this article: SPRCY Also: GWPH, JAZZ, LLY, MRK, PFE, GSK, JNJ, ABT, HEXO, NVS, TEVA
Read
SciSparc To Commence A Pre-Clinical Study Using Its SCI-210 Cannabidiol Based Treatment For Epilepsy
Article By: PR Newswire
Tuesday, March 9, 2021 4:00 PM EDT
The Company signed an agreement with The Sheba Fund for Health Services and Research at Chaim Sheba Medical Center, to examine the potential role of SCI-210 on status epilepticus.
In this article: SPRCY Also: TRPX
Read
Therapix - Out With The Old, In With The New
Article By: Kfir Silverman
Thursday, June 11, 2020 9:53 AM EDT
​It has been a hard year for Therapix which has suffered a rapid decrease in share price. We believe the company still has great potential, but has been held back as a result of management failures. It is time for a change in leadership.
In this article: TRPX, SPRCY
Read
Therapix Biosciences: Small IPO With Big League Potential
Article By: Stone Fox Capital
Wednesday, March 22, 2017 11:48 AM EDT
Therapix Bio offers investors an under the radar IPO in the hot cannabinoid market with a promising pipeline.
In this article: THXBY, TRPX, SPRCY Also: GWPH, ZYNE, OWCP, CNBX
Read
All Posts

Latest Tweets for $SPRCY

No tweets yet!

PARTNER HEADLINES

$SPRCY

Comments Status Updates
SciSparc Might Become The Next GW Pharmaceuticals
Kurt Benson • 3/24/2021 1:59:59 PM

Thanks for putting $SPRCY on my radar!

1 to 1 of 1 comments